These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29900624)

  • 1. What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
    Kiluk BD; Fitzmaurice GM; Strain EC; Weiss RD
    Addiction; 2019 Jan; 114(1):9-15. PubMed ID: 29900624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinence.
    Brandt L; Hu MC; Nunes EV; Campbell ANC
    Drug Alcohol Depend; 2023 Jul; 248():109918. PubMed ID: 37224673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
    Kiluk BD; Carroll KM; Duhig A; Falk DE; Kampman K; Lai S; Litten RZ; McCann DJ; Montoya ID; Preston KL; Skolnick P; Weisner C; Woody G; Chandler R; Detke MJ; Dunn K; Dworkin RH; Fertig J; Gewandter J; Moeller FG; Ramey T; Ryan M; Silverman K; Strain EC
    Drug Alcohol Depend; 2016 Jan; 158():1-7. PubMed ID: 26652899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.
    Terplan M; Ramanadhan S; Locke A; Longinaker N; Lui S
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD006037. PubMed ID: 25835053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome predictors in substance use disorders.
    Ciraulo DA; Piechniczek-Buczek J; Iscan EN
    Psychiatr Clin North Am; 2003 Jun; 26(2):381-409. PubMed ID: 12778840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial validation of a proxy indicator of functioning as a potential tool for establishing a clinically meaningful cocaine use outcome.
    Kiluk BD; Babuscio TA; Nich C; Carroll KM
    Drug Alcohol Depend; 2017 Oct; 179():400-407. PubMed ID: 28858744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.
    Roberts NP; Roberts PA; Jones N; Bisson JI
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010204. PubMed ID: 27040448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial interventions for stimulant use disorder.
    Minozzi S; Saulle R; Amato L; Traccis F; Agabio R
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD011866. PubMed ID: 38357958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. American counselors' acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders.
    Davis AK; Rosenberg H; Rosansky JA
    J Subst Abuse Treat; 2017 Nov; 82():29-33. PubMed ID: 29021112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal association of preference-weighted health-related quality of life measures and substance use disorder outcomes.
    Pyne JM; Tripathi S; French M; McCollister K; Rapp RC; Booth BM
    Addiction; 2011 Mar; 106(3):507-15. PubMed ID: 21205046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peer-delivered intervention to reduce harm and improve the well-being of homeless people with problem substance use: the SHARPS feasibility mixed-methods study.
    Parkes T; Matheson C; Carver H; Foster R; Budd J; Liddell D; Wallace J; Pauly B; Fotopoulou M; Burley A; Anderson I; MacLennan G
    Health Technol Assess; 2022 Feb; 26(14):1-128. PubMed ID: 35212621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term functioning to provide empirical support for the clinical relevance of treatment outcomes for methamphetamine use disorders.
    Miguel AQC; Smith CL; Burduli E; Roll JM; McPherson S
    J Subst Abuse Treat; 2021 May; 124():108291. PubMed ID: 33771286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Religiosity as a Predictor of Adolescents' Substance Use Disorder Treatment Outcomes.
    Yeterian JD; Bursik K; Kelly JF
    Subst Abus; 2015; 36(4):453-61. PubMed ID: 25222569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Fairgrieve C; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009269. PubMed ID: 30521696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of an osteopathic peer recovery coaching model on treatment outcomes in high-risk men entering residential treatment for substance use disorders.
    Crowthers RA; Arya M; Venkataraman A; Lister JJ; Cooper SE; Enich M; Stevens S; Bender E; Sanders R; Stagliano K; Jermyn RT
    J Osteopath Med; 2022 Oct; 122(10):521-529. PubMed ID: 35802066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying thresholds for clinically meaningful change among clients of drug and alcohol services using the Australian Treatment Outcomes Profile.
    Deacon RM; Mills L; Bruno R; Mammen K; Dunlop A; Childs S; Shakeshaft A; Holmes J; Lintzeris N
    Addiction; 2023 Dec; 118(12):2457-2465. PubMed ID: 37421220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal associations between pain and substance use disorder treatment outcomes.
    Ferguson E; Lewis B; Teitelbaum S; Reisfield G; Robinson M; Boissoneault J
    J Subst Abuse Treat; 2022 Dec; 143():108892. PubMed ID: 36228338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.